bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-21-1623

Order Name:
NeoGen Newborn Screening **

 
Useful For:
First Step will screen for the following Inborn Errors of Metabolism (also known as Metabolic Disorders) by Tandem Mass Spectrometry and Biochemical Analysis. Newborns are screened from a dried blood spot, ideally collected within 24 to 72 hours of birth.

This service is stand for the biggest panel: Hb+FS+ (57 disorders screen)
 
Methodology:
TMS, FEA, FEIA, Fluorimetry, HPLC
 
Test List In Profile:
Acylcarnitine Profile (TMS)
Amino Acid Profile (TMS)
G6PD Deficiency (FEA)
Congenital Adrenal Hyperplasia (FEIA)
Cystic Fibrosis (FEIA)
Galactosemia (Fluorimetry)
Congenital Hypothyroidism (FEIA)
Biotinidase Deficiency (FEA)
Hemoglobinopathies (HPLC)
 
AliasesName:
NeoGen Newborn Screening: Hb+FS+
First Step™ NEWBORN SCREENING TEST, Neogen
 
 
 
Test Code:
090-21-1623

Order Name:
NeoGen Newborn Screening **

 
Patient Preparation:
Recommend to collecton sample 24 to 72 hours of birth.
 
Collection Specimen Or Container:
5 blood spots/ NeoGen's Filter paper card

Document Required
Patient history filled completely in the NeoGen Labs Form
 
Specimen Testing Type:
Dried blood spots
 
Sub Mission Container:
Filter paper card
 
Rejection Criteria:
Invalid specimen:
  • Specimen quantity insufficient for testing.
  • Specimen appears scratched or abraded.
  • Specimen appears diluted, discolored or contaminated.
  • Specimen appears supersaturated.
  • Specimen not dry before sending.
  • Specimen exhibits serum rings.
  • Specimen appears clotted or layered.
 
 
 
Test Code:
090-21-1623

Order Name:
NeoGen Newborn Screening **

 
Method detail:
TMS, FEA, FEIA, Fluorimetry, HPLC
 
Schedule:
N/A **Sent Out to NeoGen Labs, India
 
Turnaround Time:
Received specimen to reported within 2 weeks
 
Performing Location:
NeoGen Labs, India
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-21-1623

Order Name:
NeoGen Newborn Screening **

 
 
Clinical Information:
Newborn Screening ในกรณีแพทย์มีโรคที่สงสัย หรือต้องการ Screen โรคเพิ่มขึ้น
ประกอบด้วย
Disorders Detected by Tandem Mass Spectrometry
- Acylcarnitine Profile (Fatty Acid Oxidation Disorders)
- Acylcarnitine Profile (Organic Acid Disorders)
- Amino Acid Profile (Amino Acid Disorders)
- Lysosomal Storage Disorders (LSD)
- Others
Disorders Detected by Other Technologies
- Congenital Hypothyroidism (CH)
- Congenital Adrenal Hyperplasia (CAH)
- Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD)
- Galactosemia (GALT)
- Biotinidase (BIOT)
- Cystic Fibrosis (CF)
- Hemoglobinopathies (HP)
- Phenylketonuria (PKU)

First Step Newborn Screening Test is done 24 hours AFTER a baby is born to identify serious Metabolic disorders (IEMs or Inborn Errors of Metabolism) the baby may have been born with. These disorders, if undetected and untreated, can have adverse consequences for a baby’s health.
 
If a baby is born with a disorder, a Newborn Screening Test helps detect the disorder early so treatments can start before the disorder causes any harm to the baby.
 
These disorders are inherited and cannot be prevented but they are TREATABLE. Even healthy looking babies and babies with no family history of such disorders may have them. If a baby is born with a disorder, early detection and treatment is the only solution. Failure to start the treatment in time may result in mental retardation, physical disability or even death.
 
Reference Value:
Within Normal Limits
 
Interpretation:
Newborn Screening Limitations
Due to biologic variability of newborns and differences in detection rates for the various disorders in the newborn period, Newborn Screening will not identify all newborns with these conditions. While a positive screening result identifies newborns at an increased risk to justify a diagnostic work-up, a negative screening result does not rule out the possibility of a disorder. Healthcare providers should remain vigilant for any signs or symptoms of these disorders in their patients. The screening process is best coordinated with a physician.